The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Ligand and Target Discovery by Fragment-Based Screening in Human Cells
Open accessAbstract
Advances in the synthesis and screening of small-molecule libraries have accelerated the discovery of chemical probes for studying biological processes. Still, only a small fraction of the human proteome has chemical ligands. Here, we describe a platform that marries fragment-based ligand discovery with quantitative chemical proteomics to map thousands of reversible small molecule-protein interactions directly in human cells, many of which can be site-specifically determined. We show that fragment hits can be advanced to furnish selective ligands that affect the activity of proteins heretofore lacking chemical probes. We further combine fragment-based chemical proteomics with phenotypic screening to identify small molecules that promote adipocyte differentiation by engaging the poorly characterized membrane protein PGRMC2. Fragment-based screening in human cells thus provides an extensive proteome-wide map of protein ligandability and facilitates the coordinated discovery of bioactive small molecules and their molecular targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Equipping noncovalent fragments with a photoreactive diazirine moiety similarly enables their proteome-wide target identification without the prerequisite of a particular amino acid in or nearby a ligandable site.98−100”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [98]
In the citing paper
“We recently introduced a strategy that integrates FBLD with chemical proteomics to globally assess small molecule-protein interactions in human cells13.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“As a consequence, we found that individual FFF probes showed substantial differences in their overall proteomic interaction profiles, which made for complicated structure-activity relationships (SARs) requiring careful manual review to identify fragment-protein interactions that reflected authentic recognition events (versus simply correlating with the overall proteomic interaction profiles of the”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“Moreover, while many of the enantioprobe targets were also enriched by members of the original FFF probe set13, these previous profiles often did not provide useful SAR information, either reflecting substantial enrichment by all of the FFF probes or mirroring the respective global protein interaction footprints of these probes (Supplementary Fig. 2).”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“Nonetheless, we also found that individual FFFs showed substantially different overall protein interaction profiles in human cells, which complicated the assignment of small molecule-protein interactions displaying authentic SARs (vs nonspecific binding to the FFFs).”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“The initial set of fully functionalized (clickable, photoreactive) fragments (FFFs) uncovered many new small molecule-protein interactions, some of which were advanced to selective and cell-active chemical probes.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
In the citing paper
“We previously described a chemical proteomic strategy to perform fragment-based ligand discovery experiments in human cells13.”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
Washburn, M. P., Wolters, D. A., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,768
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Computational Methods in Drug Discovery
Sliwoski, G. R., Kothiwale, S., Meiler, J., & Lowe, E. W. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,306
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 2,002
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Fpocket: An open source platform for ligand pocket detection
Guilloux, V. L., Schmidtke, P., & Tufféry, P. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-168 · Cited by 1,724
Quantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684
Self-citationPrivileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302
Research works printed but not linked: 1
- Gerdes, 1998, Cloning and tissue expression of two putative steroid membrane receptors, Biol. Chem., 379, 907
Cited by
Sorted by citations
Items 401–445 of 445
Racioppo, B., Pechalrieu, D., Abegg, D., Dwyer, B. G., Ramseier, N. T., Hu, Y., & Adibekian, A. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-4nm88
Racioppo, B., Pechalrieu, D., Abegg, D., Dwyer, B. G., Ramseier, N. T., Hu, Y., & Adibekian, A. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-4nm88-v2
Emerging Technologies for Epigenetic Drug Discovery
(2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-part2
Mass Spectrometry and Chemical Biology Approaches for Deconvoluting Epigenetic Targets
Burton, A. J., Hamza, G. M., Iannetta, A. A., Miele, E., & Zhang, A. X. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-00050
Jackson, P. A., Kisty, E. A., Pradhan, V., Swank, C., Bohrer, L., Nolan, T. L., Weerapana, E., & Lapinsky, D. J. (2024) · ACS Omega · doi:10.1021/acsomega.4c06879
Design and Construction of a Fully Functionalised Probe Library for Mode of Action StudiesPreprint
Holik, Y., Murugesan, D., Patterson, S., Wyllie, S., Ian, H. G., Zuccotto, F., & Gary, J. T. (2025) · ChemRxiv · doi:10.26434/chemrxiv-2025-4vn1q
Design and Construction of a Fully Functionalised Probe Library for Mode of Action StudiesPreprint
Holik, Y., Murugesan, D., Patterson, S., Wyllie, S., Ian, H. G., Zuccotto, F., & Gary, J. T. (2025) · ChemRxiv · doi:10.26434/chemrxiv-2025-4vn1q-v2
Design and Construction of a Fully Functionalised Probe Library for Mode of Action StudiesPreprint
Holik, Y., Murugesan, D., Patterson, S., Wyllie, S., Ian, H. G., Zuccotto, F., & Gary, J. T. (2025) · ChemRxiv · doi:10.26434/chemrxiv-2025-4vn1q-v3
Target Agnostic Photoaffinity Labelling by Sulfonylhydrazones
Garami, K. N., Péczka, N., Petri, L., Imre, T., Langó, T., Szabó, Z., Orgován, Z., Szabó, P. T., Keserű, G. M., & Ábrányi‐Balogh, P. (2025) · Angewandte Chemie · doi:10.1002/ange.202408701
Design and Construction of a Fully Functionalised Probe Library for Mode of Action StudiesPreprint
Holik, Y., Murugesan, D., Patterson, S., Wyllie, S., Ian, H. G., Zuccotto, F., & Gary, J. T. (2025) · ChemRxiv · doi:10.26434/chemrxiv-2025-4vn1q-v4
Garner, A. L., Bonnet, M., Carozza, C. A., Eby, O. G., & Dean, M. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00015-7
Chang, W., Zhang, B., Yang, S., Zhang, X., Zhang, L., Zhang, S., Lu, J., Wang, W., Shang, P., & Yue, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-12192-3
Olushola‐Siedoks, A. A., Small, L., Fincham, K. J., Wai, D. C. C., Monteiro, D., Conway, J. R. W., Cadell, A. L., Parker, B. J., Croucher, D. R., Schmitz‐Peiffer, C., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120071
EROS protein: Decoding its pivotal role in redox homeostasis and disease pathogenesis
Liang, S., Zhou, Y., Ren, W., Xu, Y., Tang, M., Su, Y., Li, L., & Gao, M. (2025) · Advances in Redox Research · doi:10.1016/j.arres.2025.100147
Identification of PTGR2 inhibitors as a new therapy for diabetes and obesityPreprint
Chang, Y., Hsieh, M.-L., Lee, H.-L., Hee, S.-W., Chang, C.-F., Yen, H., Chen, Y.-A., Chen, Y.-R., Chou, Y.-W., Li, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.17.629058
Kim, A. S., Ma, K., Reinhardt, C. J., Lazar, D. C., Ogasawara, D., Shaw, T. M., de la Torre, J. C., Bailey, A. L., Melillo, B. N., Teijaro, J. R., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524108123
Self-citationMapping ortholog-restricted ligandable cysteines in the wheat pathogen Zymoseptoria triticiPreprint
Yoo, M., Ware, T. B., Moschen, S., Reed, A., Reinhardt, C. J., Njomen, E., Thacker, U., Melillo, B. N., Scalliet, G., Paşcanu, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.16.706151
Self-citationDT-TRAP enables accurate target recognition via simplified dosing and low-temperature incubation
Zhang, H., Yuan, W., Li, Y., Li, C., Xie, Y., Wan, N., Hao, H., & Ye, H. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101605
Chemical probes to interrogate biological systems
Ende, C. W. A., Field, S. D., Majmudar, J. D., & Schenone, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00055-8
Cauwel, M. (2021) · theses.fr (ABES) · doi:10.70675/e5004e36z3ddfz46c5zafb0z41e7a8835263
Méthodes de synthèse de ligands et sondes chimiques d'ARN
Fleurisson, C. (2023) · theses.fr (ABES) · doi:10.70675/9501ea44ze354z4e26zb92bzcd007e6cf9c9
Yang, X., Taghavi, A., Akahori, Y., Pedrini, M., Ishii, T., & Disney, M. D. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00337
Brodie, G., Sayed, A., Kreuz, S., Fischle, W., & Conway, S. J. (2026) · RSC Chemical Biology · doi:10.1039/d6cb00148c
Wilders, H., Grant, E. K., & Bush, J. T. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02242-w
Proteomics‐Driven Strategies for Proximity‐Inducing Drug Discovery
Fan, R., Ni, J., Zhou, T., Jiang, H. Q., Zhao, W., & Tan, M. (2026) · Angewandte Chemie · doi:10.1002/ange.3307512
Benzoxaboroles Are Structurally Unique Binders of Eukaryotic Translation Initiation Factor 4E
Combs, J. B., Peacock, D. M., Craven, G. B., Jung, S., Chen, Y., Le, S. M., Taunton, J., & Shokat, K. M. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c04291 · Cited by 1
Waters, J. E., Wilders, H., Biggs, G. S., Kintzel, M., Cawood, E. E., Bailey, J., Maslen, S., Yip, Y. M., Wakley, M., Riziotis, I. G., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.8867549
Multidisciplinary Approaches to Heterocyclic Oncology Research
Goti, V., Verma, A., & Armo, R. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898817084126010014
Chemical Biology 2025: Highlights From the Ch/Bi145 Course at Caltech
Ashton-Rickardt, G. P., Chung, D. K., Corman, S. A., Gilbert, M. S., Green, Z. B., Hengartner, E. R., Hou, J., Kang, D., Konsler, J. K., Kuleshova, I. D., et al. (2026) · ChemBioChem · doi:10.1002/cbic.70485
Progress and challenges in traceless ligand-directed labelling chemistry
Hopkinson, T., Cox, L. R., & Wilson, A. J. (2026) · Communications Chemistry · doi:10.1038/s42004-026-02222-0
Human prostaglandin reductases dearomatize and inactivate benzothiazinone antitubercular drugs
Briki, M., Wagner, C., Desfontaine, V., Vocat, A., Opota, O., Abou-Zite, S., Corpataux, O., Cena, B., Guinchard, S., Versace, F., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00526-1
Wu, F., 张永明, Yao, H., & Ni, F. (2026) · Organic & Biomolecular Chemistry · doi:10.1039/d6ob01537a
Liu, T., Du, L., Ma, W., Long, G., Liu, D., & Li, X. (2026) · Advanced Materials · doi:10.1002/adma.75522
BindingDB Entry 50019714: Fragment-Based Approaches to Identify RNA Binders.
BindingDB (2024) · UC San Diego · doi:10.7270/q20z77ps
BindingDB Entry 50010106: Fragment-to-Lead Medicinal Chemistry Publications in 2017.
BindingDB (2021) · UC San Diego · doi:10.7270/q22b92hn
BindingDB Entry 50008548: Fragment-to-Lead Medicinal Chemistry Publications in 2018.
BindingDB (2021) · UC San Diego · doi:10.7270/q2zg6wm7
BindingDB Entry 50007948: The Druggability of Solute Carriers.
BindingDB (2021) · UC San Diego · doi:10.7270/q26113pd
BindingDB Entry 50003270: Lead-like Drugs: A Perspective.
BindingDB (2020) · UC San Diego · doi:10.7270/q2qv3q7q
BindingDB Entry 50000310: Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors.
BindingDB (2019) · UC San Diego · doi:10.7270/q2gx4dz9
Shinde, M. D., Kabra, U. D., Umekar, M. J., & Lohiya, R. T. (2026) · Russian Journal of General Chemistry · doi:10.1134/s1070363226603303
Metadata
- Authors
- Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., Narvaiza, I., Saez, E., & Cravatt, B. F.
- Affiliations
- Scripps Research Institute (US)
- École Polytechnique Fédérale de Lausanne (CH)
- Bristol-Myers Squibb (United States) (US)
- Salk Institute for Biological Studies (US)
- Corresponding author
- Parker, Christopher G.
- Cravatt, Benjamin F.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 168
- Issue
- 3
- Pages
- 527-541.e29
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5632530
- OpenAlex
- W2575838842
- Cited by
- 439
- References
- 59
- Citations by year
- 2026: 29 · 2025: 44 · 2024: 42 · 2023: 49 · 2022: 55 · 2021: 50 · 2020: 49 · 2019: 52 · 2018: 39 · 2017: 29
- FWCI
- 19.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- American Cancer Society (PF-14-100-01-CDD)
- American Heart Association (14POST18200019)
- NIH (DK099810, CA132630, 1S10OD16357)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- fragment screening, chemical probes, protein-ligand interactions, human proteome, target identification, PGRMC2, adipogenesis, membrane proteins, site-specific binding, phenotypic screening, ligand discovery
- MeSH terms
- Cell Differentiation, Humans, Hydrolases, Ligands, Membrane Proteins, Oxidoreductases, Protein Binding, Receptors, Progesterone, Adipocytes, Crystallography, X-Ray, Proteomics, Small Molecule Libraries, Drug Discovery, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
